Table 2. Pairwise comparison of all outcomes.
Outcomes | Estimate (MD) | Studies (n) | Patients (n) | l-95% CrI | u-95% CrI | RSRF | SD(Intercept) | sd-l-95% CrI | |
CT | CG | ||||||||
HbA1c (%) | −0.48 | 17 | 823 | 758 | −0.55 | −0.4 | 1 | 0.31 | 0.17 |
FBG | −7.58 | 13 | 657 | 644 | −12.17 | −2.95 | 1 | 17.73 | 11.23 |
BMI | −0.61 | 14 | 817 | 796 | −1.03 | −0.19 | 1 | 0.17 | 0.01 |
BFP | −1.1 | 9 | 238 | 224 | −1.64 | −0.58 | 1 | 0.27 | 0.01 |
SBP | −2.19 | 12 | 466 | 441 | −3.87 | −0.54 | 1 | 1.57 | 0.03 |
DBP | −1.36 | 12 | 745 | 720 | −2.74 | −0.06 | 1 | 2.75 | 1.24 |
BFPbody fat percentageBMIbody mass indexCGcontrol groupCTconcurrent aerobic combined resistance trainingDBPdiastolic blood pressureFBGfasting blood glucoseHbA1c (%)glycosylated hemoglobinl-95% CIlower limit of 95% credible intervalMDmean differenceSBPsystolic blood pressureSD(Intercept)standard deviation of the random interceptu-95% CIupper limit of 95% credible intervalVO2maxmaximal oxygen uptake